managing the cv care reemergence...apr 28, 2020 · this presentation is for general information...
TRANSCRIPT
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
MANAGING THE CV CARE REEMERGENCEBeginning to Prepare for Post-COVID Patient Needs – Part 1
April 28, 2020
PRESENTERS:• Ginger Biesbrock, PA-C, MPH, MPAS, AACC• Cathie Biga, MSN, RN, FACC• Nicole Knight, LPN, CPC, CCS-P• Terri McDonald, RN, MBA, CPHQ,
MODERATORS:• Jerry Blackwell, MD, MBA, FACC• Lori Walsh, MHSA
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 2
Attendee Control Panel (Example)• Grab Tab – Click arrow to open/close
Control Panel.
• Muted
• View in Fullscreen mode
• Raise Hand – When vocal questions/comments are allowed, please select the hand icon to get the presenter’s attention. A red arrow means your hand is raised.
• Handouts – when available, you are now able to download handout materials from this pane.
Audio PIN: #
• Audio pane – Select audio format. Select Telephone or Mic & Speakers devices. When using telephone, be sure to use your pin number (located here).
• Questions pane – If turned on by an organizer, attendees can submit questions and review answers. Broadcast messages to attendees will also show here.
− Type your question and click Send to submit it to the organizer
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
[ ]DISCLAIMERThis presentation is for general information purposes only and is not intended and does not constitute legal, reimbursement, coding, business or other advice. Furthermore, it is not intended to increase or maximize payment by any payer. Nothing in this presentation should be construed as a guarantee by
MedAxiom regarding levels of reimbursement, payment or charge, or that reimbursement or other payment will be received. Similarly, nothing in this presentation should be viewed as instructions for
selecting any particular code. The ultimate responsibility for coding and obtaining payment/reimbursement remains with the customer. This includes the responsibility for accuracy and
veracity of all coding and claims submitted to third party payers. Also note that the information presented herein represents only one of many potential scenarios, based on the assumptions,
variables and data presented. In addition, the customer should note that laws, regulations, coverage and coding policies are complex and updated frequently. Therefore, the customer should check with their local carriers or intermediaries often and should consult with legal counsel or a financial, coding or reimbursement specialist for any coding, reimbursement or billing questions or related issues. This
information is for reference purposes only. It is not provided or authorized for marketing use.
3
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 4
Cathleen Biga, MSN, FACCPRESIDENT/CEO, CARDIOVASCULAR MANAGEMENT OF IL [email protected]
EMERGENCE: LIVING WITH COVID
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Like the Phoenix …we need to emerge
5
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 6
TO A DIFFERENT WORLD
Short term cash flow strategy
A strategic, detailed, and phased emergence plan
Keep all your providers close –interventionalists perhaps a tad closer
Define and convene a governance committee
‒ NI‒ Cath Lab‒ EP‒ Clinic
Check your hospital’s plan
‒ System plan
Check your state’s Department of Public Health
Stay on top of CDC guidelines
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
COVID-19 Awarenessü Know your zip codeü Incidenceü Prevalenceü Clustersü CDC guidelines
Preparedness ü PPEü Testingü Supply chainü HR
Patient Safetyü Communicationü Screeningü Testingü Visitorsü Social Distancing
START YOUR PLANNING NOW
7
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Clinic• New pts• Symptomatic pts• Pts w/o video• Social distance• Masks• Logistics
Imaging • Testing – pts.• PPE – staff• Logistics• Longer hours
Procedures• Daily dashboard• Beds & ventilators • PPE, testing (HCW &
pt.)• Week behind clinic
Coming to grips with reality
OUR EMERGENCE
8
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 9
Determine YOUR tier process for procedures
Implement new policies and procedures
Re-engage staff and listen to them
Develop and implement internal and external communication
Confirm you can manage “elective” procedures
SUMMARY
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
The Gottleib report (which was written by small team of public health, health security, epidemiological, and medical professionals) is one of the best reports we’ve seen that provides a map forward for re-opening the US: National Coronavirus Response - Gottlieb
This Harvard report (which cross-references some of Gottleib’s recommendations): Roadmap to Pandemic Resilience - Harvard's Center for Ethics
This NGA report has an excellent reference table in the Appendix (pages 29-33) that shows a side by side comparison of all the major reports/guidance published to date, and how they compare on each element: Roadmap to Recovery – National Governor’s Association
10
REFERENCES
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Whitehouse: https://www.whitehouse.gov/openingamerica/#criteriaCMS: https://www.cms.gov/files/document/covid-flexibility-reopen-essential-non-covid-services.pdf
The Guidelines for Opening Up
America Again can be found here:
11
EMERGENCE…
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 12
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 13
Ginger Biesbrock, PA-C, MPH, MPAS, AACCSENIOR VICE PRESIDENT, CONSULTING
COVID #4 UPDATE
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
COVID-19 Surveillance
COVID-19 Safety –Employees and Patients
Reemergence Preparedness –Defining the New Normal
Develop a Task Force – with Representation from All Areas
Considerations
14
REEMERGENCE
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Physician Champion(s)AdministratorClerical - scheduling, registrationClinical - MA, RN, APPRevenue CycleImaging, Ancillary, Procedural Services
Key Stakeholders
REEMERGENCE TASK FORCE
15
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Ambulatory Clinic and Imaging
Procedural Care Ancillary Services and Revenue Cycle
Where to Start
16
REEMERGENCE
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
COVID-19 Positive • Worker
‒ Definitions for safety to return
‒ Plans for quarantine of those possibly exposed
• Patient
COVID-19 Person Under Investigation
MUST-HAVE POLICIES
17
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 18
COVID-19 SCREENING POLICY
Staff• Screening daily
Patient • Screening day prior• Screening day of• Possible testing for those
that undergo procedure or possible imaging
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
All staff should wear a face mask
Patients should wear face masks from home – or be provided one in the office
Assure hand washing and sanitizer stations to your infectious disease code
Room cleaning and wipe down
Definitions for terminal clean requirements
19
COVID-19 PPE AND CLEANING POLICY
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Review of Facility:
• Are you part of a hospital campus, building? • Setting up ‘clean’ entrances and exits• Option for providing care in the car?
• Coumadin clinics• Imaging areas – are they shared with inpatients?• Procedural areas – are they shared with inpatients
20
Non
-CO
VID
C
are
Zone
s:
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
• 6 feet apart• Waiting in car
with text or pager when ready
• Discourage additional visitors (limit to 1 caretaker)
• Pre-register with virtual if possible
• 6 feet with separation of registrar and patient – review your facility
• Minimize ‘touches’
• Paper vs portal
• Pre-visit phone call
• Weights, blood pressure and 02
Waiting Room Registration Patient Rooming
• Room check-out for simple
• Virtual check-out for complex
• Develop separate processes to minimize touchpoints
Check-out
PATIENT FLOW CONSIDERATIONS
21
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Limit patient flow
Spread your clinics out throughout the week – extend hours
Evaluate clinic capacity – reduce to appropriate # of maintain social distancing
Develop a clinic triage plan
PATIENT SCHEDULING PEARLS
22
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Develop clinical care pathway based on patient type:
Acute NeedsUrgent Needs – high risk chronic disease managementStable Needs – chronic disease managementPrevention
Delivery options:Face-to-face office visitsTelehealth visitsRemote patient monitoring, chronic care management
23
CLINIC TRIAGE PLAN
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 24
Ambulatory Management FrameworkAcute & New Patient Chronic Disease Mgmt. Prevention
In Office In OfficeIn Office
Telehealth Telehealth
Remote Patient Monitoring
24
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
TELEHEALTH VISIT FLOW
25
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
FACE-TO-FACE VISIT FLOW
26
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
STRESS TESTINGCONSIDERATIONS
27
Ginger Biesbrock, PA-C, MPH, MPAS, AACCSENIOR VICE PRESIDENT, CONSULTING
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 28
• Level of risk of patient transmitting COVID-19 to imaging team
• *Urgency of performing the test
• COVID screening question
• Instructions/what to expect for the day of the test
PRE-TEST CONSIDERATIONS
1 2Evaluate for: Call patient day prior:
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 29
Screen patient for COVID risk +/- temperature
All patients should wear facemasks
Maintain 6 feet as much as possible
Patient should come alone if possible
All patient-facing staff should wear a facemask at all times
DAY OF TEST CONSIDERATIONS
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
If COVID suspected, one tech to don PPE and other to run the scanner
Terminal clean if patient COVID+ or concerns for COVID+
ALL equipment should be cleaned between each test in compliance with local infection control policies
Minimize # of staff required to provide face to face patient interaction and minimize amount of time with patient by assuring all needs are met with each interaction
DURING TEST CONSIDERATIONS - NUCLEAR
Guidance and Best Practices for Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC and SNMMI 30
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Plan ahead for echo to allow for focused sequences of images that are needed for decision making
Consider increased use of ultrasound enhancing agent to improve image acquisition
Minimize scan times by excluding students and novice practitioners
DURING TEST CONSIDERATIONS - ECHO
https://www.asecho.org/ase-statement-covid-19/31
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Select protocol with shortest duration of scan timeSingle day or stress only Consider PET if available – faster throughputConsider minimize treadmill use – utilize pharmacologic as preferred for both echo and nuclearConsider pharmacologic agent with shortest infusion time, etc.
Goal is to minimize exposure
PROTOCOL CONSIDERATIONS
32
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
RESUMING INVASIVE LAB OPERATIONSWhat Does That Look Like?
33
Terri McDonald, RN, MBA, CPHQVICE PRESIDENT, CONSULTING
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Protect the health and safety of patients,
healthcare workers, and the community through
mitigating the risk of viral spread
*Creating Non-COVID Care (NCC) Zones*
Resume interventional procedures essential to
cardiovascular health for our patients
PLAN WITH OVERARCHING PRINCIPLES
34
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Multidisciplinary, authorized to make real-time decisions: clinical, operational, financialAwareness of community statusDefine and implement policiesDynamic management and application of emerging information and knowledgeOversight of outcomes, with a plan for potential return to containment
Steering/ Governance
Team
WHERE TO START?
35
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Hospital/System Leadership and Infection Prevention Team
Chain of command for your community: state, county, municipal
ACC's COVID-19 Hub
MedAxiom COVID-19 Resources for CV Organizations
Key
Res
ourc
esLOCAL, REGIONAL AND NATIONAL TRENDS
36
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
ü Initial COVID-19 screening questionnaire
ü Pre-procedure assessments (nursing, anesthesia, H&P)
ü Patient educationü Registration/questionnaires
ü Access to clinical personnel for issues
ü 24-hour follow-up call post-procedure
ü Consider post procedure screening for COVID/ILI at seven and 14 days
ü Post procedure provider visit (routine guidelines)
Pre-procedure
IT infrastructure should support minimizing in-person interactions
LEVERAGE VIRTUAL/TELEHEALTH RESOURCES
37
Post-procedure
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
CONSIDERATIONS FOR TIMING (PHASE ONE)
38
Access to/level of testing
Sustained reduction in average number of cases for 14 days in your geography
Authorized by appropriate authorities
Hospital not at crisis level
(Example)
Zip
Cod
e M
atte
rs
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
• Return repurposed areas/equipment to use
• Maintenance and safety checks
• Engineer screening at all entry points and social distancing where possible
• Everyone masked, at all times
• Standard full -barrier precautions in procedures*
• Adequate supply without reuse
• Policies for use and conservation of supply
• Uninterrupted supply chain
• Inventory adequate to support sustained operation
• Policies for Industry Rep
Facility PPE Supply Chain
• Adequate number of trained and educated staff available
• Staffing plan supports gradual resumption of case volumes
• EVS support
Staffing
And turn the faucet back on slowly in Phase One
39
ACTIONS/RESOURCES TO CREATE NCC ZONES
*Healthcare Infection Prevention and Control FAQs for COVID-19
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Sensitive to the institution’s resources, priorities, and patient needs – Phase One will drive SDD as a priority
Transparency in process
Defined, evidence-based criteria, begins with an assessment of the backlog
Dynamic – will be modified as more COVID-related outcome data become available
Collaborative, multidisciplinary collaboration – Steering Committee authority
*Cre
ate
Fram
ewor
kCASE PRIORITIZATION
40*Source: Local Resumption of Elective Surgery Guidance (ACOS April 2020)
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
In hospital-based labs reserve one lab for known COVID-19 and PUI (urgent/emergent) if possible; this is core work/staffing *lab turn-around time considerations*
Start week 1 at 25% elective capacity with block scheduling (adjust starting point as resources allow)
Evaluate and adjust weekly (Steering Committee oversight)
RESUME/RAMP-UP PLAN: PHASE ONE
41
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 42
REVENUE CYCLECONSIDERATIONS
Nicole Knight, LPN, CPC, CCS-PVICE PRESIDENT REVENUE CYLE SOLUTIONS AND CONSULTING
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
CPT® DISCLAIMER
• CPT® copyright 2020 American Medical Association. All rights reserved.
• CPT® is a registered trademark of the American Medical Association
4343
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Maintaining Virtual Clinics – Coumadin, Device, Telehealth Visits
How to Make Remote Patient Monitoring (RPM) Happen?
Exploring Chronic and Principle Care Management (CCM, PCM) Opportunities
Pre and Post Visit Prep and Planning
CONSIDERATIONS
44
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 45
• Registration, ID, Insurance Card • Insurance Verification• Referral and/or Authorization Requirements• Patient Responsibility• Considerations of Electronic/Digital Signature forms
• Ensure all registration and insurance eligibility is done• Collections prior to visit – growing self insured.
• Appointment or recall is crucial• Schedule and/or coordinate labs, testing, etc.• Orders reconciliation process
Pre-Visit
At the Visit
Post Visit
In-Person or Virtual SAME
Considerations
VISIT PREPARATION AND PLANNING
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Remote Device Clinics – pacemaker, ICD, Optivol, etc.
Accountability and ownership of virtual services that may not have existed with movement to safe in person visits
Coumadin Clinic – Capturing management codes, home INR, % require in-person, continuing curb side.
#1 = What % will require in-person? Solid process to capture charges/time- frames and any potential overlapping services.
MAINTAINING AND CONVERTING SERVICES
46
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Expiration date? Moving forward w/ telehealth
Patients loss to follow – no shows, cx’s, recalls, etc.
Out of hospital patients – TCM
Challenges with technology
Reimbursement and guidance – Medicare vs. commercials
Denials, re-work of claims, etc.
TELEHEALTH PLANNING
47
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
WHAT WE KNOW NOW
48
Telehealth for CMS remains AUDIO and VIDEO
Some commercial payers are paying for regular EM’s for just telephone – variable by state.
Challenges with cost sharing, copays, legal and compliance –key is to be consistent across your program.
Hospital visits, consults, etc. remain a gray zone – programs doing what makes sense..
Claims processing versus holding
Denial management – tracking and re-work
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
• Provider Prescription and/or Order Required
• Annual Consent Required -may be verbal or written
• Education on coinsurance, copay, etc.
DURING COVID PHE• New and Est pts
• Chronic or Acute Conditions
• Device = FDA’s definition of medical device.
• Device capable of generating and transmitting recordings of the pt’sphysiologic data..
• Consideration of the data collected and integration.
• If supplying device - must be supplied for at least 16 days to bill. Understand requirements of lease or purchase of equipment
• May be performed by the MD, QHP, or by clinical staff depending on the CPT.
• Clinical staff may include RNs and MAs, depending on state law.
• General Supervision 2020
• No previous visit 7 days prior or in 24 hrs/soon as possible.
• Not allowed for RHC and FQHCs
• May be reported with TCM, CCM but no double counting time.
Pt. Eligibility Technical Regulatory
Areas of Guidance
REMOTE PATIENT MONITORING (RPM)
49
DURING COVID PHE – FDA Expanded use of RPM devices
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Coding and Billing
RPM REV CYCLE
50
Click here to access MedAxiom’s Virtual Services Tool
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 51
CLINICAL DOCUMENTATION
Consent – verbal or written Capturing the dates and actual time spent providing the non-face to-face services for the 30-day period
Care team member providing services (with credentials if applicable)
A brief description of the services provided• Data Monitoring: reviewing incoming
data, discussing data with patients, flagging areas of concern, etc.
• Managing Interventions: making medical decisions based on data, reaching out in emergency situations, discussing medical changes with patients, etc.
CMS has not defined what constitutes a “live interactive communication,” we assume a face-to-face visit, an interactive video conference or a conversation by telephone or text message should be sufficient
Attestation of the provider i.e. signature (support general supervision, review, etc.)
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Option for managing 1 or more chronic illnesses
Consideration for support from care team – general supervision
Improved care coordination, outcomes, engagements, etc.
Impact on revenue – non face to face services. Studies show $75,000 + per provider annual revenue.
Virtual enrollment – E&M and if applicable G0506 – CCM Initiating Visit via Telehealth
Comes with documentation and reimbursement requirements
CONSIDERING CCM OR PCM
52
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
MedAxiom.com/COVID19
MEDAXIOM’S COVID-19 RESOURCES
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 54
ACCESS THE TOOL
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 55
TAKE THE SURVEY
SURVEY ON STEMI AND STROKE VOLUMES
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
Q&A56
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 57
• ACC/SCAI Consensus Document: Triage For Structural Heart Disease During COVID-19 Pandemic - American College of Cardiology
• ACC/SCAI/ACEP Consensus Statement on Management of AMI Patients During COVID-19 -American College of Cardiology
• Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19)
RESOURCES FOR CV CASE PRIORITIZATION
• CDC: Coronavirus (COVID-19)• CDC Interim Infection Prevention and Control Recommendations for Patients with Suspected or
Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings• Return to Work for Healthcare Personnel with Confirmed or Suspected COVID-19• Opening Up America Again | The White House• Joint Statement: Roadmap for Resuming Elective Surgery after COVID-19 Pandemic• AORN Townhall: Roadmap for Resuming Elective Surgery - What it Means to You on the Front Line
ADDITIONAL RESOURCES
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION
• https://www.heart.org/-/media/files/about-us/policy-research/policy-positions/clinical-care/remote-patient-monitoring-guidance-2019.pdf?la=en&hash=A98793D5A043AB9940424B8FB91D2E8D5A5B6BEB
• https://www.ama-assn.org/amaone/ama-digital-health-implementation-playbook
• https://www.cms.gov/outreach-and-education/medicare-learning-network-mln/mlnproducts/downloads/chroniccaremanagement.pdf
• https://innovation.cms.gov/files/reports/chronic-care-mngmt-finalevalrpt.pdf
• https://www.cdc.gov/coronavirus/2019-ncov/downloads/critical-workers-implementing-safety-practices.pdf
RESOURCES
58
© 2020 MedAxiom DO NOT DISTRIBUTE WITHOUT PERMISSION 59
Cathleen Biga, MSN, FACCPRESIDENT/CEO CARDIOVASCULAR MGMT OF IL [email protected]
Nicole Knight, LPN, CPC, CCS-PVICE PRESIDENT REVENUE CYLE SOLUTIONS AND [email protected]
Terri McDonald, RN, MBA, CPHQVICE PRESIDENT, [email protected]
Ginger Biesbrock, PA-C, MPH, MPAS, AACCSENIOR VICE PRESIDENT, [email protected]